L

Lumos Diagnostics Holdings Ltd
ASX:LDX

Watchlist Manager
Lumos Diagnostics Holdings Ltd
ASX:LDX
Watchlist
Price: 0.275 AUD -1.79% Market Closed
Market Cap: AU$216.5m

Relative Value

LDX doesn't have a meaningful market cap.

The Relative Value of one LDX stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.275 AUD, Lumos Diagnostics Holdings Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LDX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

LDX Competitors Multiples
Lumos Diagnostics Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Lumos Diagnostics Holdings Ltd
ASX:LDX
209.6m AUD 11.5 -19.9 -23.7 -23.7
US
Medline Inc
NASDAQ:MDLN
65.4B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
9.3T JPY 10.2 37.2 26.5 31.9
CH
Alcon AG
SIX:ALC
31.6B CHF 4 39.3 16.2 31.5
DK
Coloplast A/S
CSE:COLO B
108.4B DKK 3.9 27.2 14.2 16.9
US
Align Technology Inc
NASDAQ:ALGN
12.8B USD 3.2 31.3 16.6 21.6
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.2 -17.5 18 58.3
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.8 29.9 13.2 21.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
40.9B CNY 9 24.8 22.3 22.3
JP
Asahi Intecc Co Ltd
TSE:7747
790.8B JPY 6.1 44.7 21 28.5
CH
Ypsomed Holding AG
SIX:YPSN
3.8B CHF 4.8 19.3 12.6 17.1
P/E Multiple
Earnings Growth PEG
AU
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Average P/E: 31.7
Negative Multiple: -19.9
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
22%
N/A
JP
Hoya Corp
TSE:7741
37.2
13%
2.9
CH
Alcon AG
SIX:ALC
39.3
25%
1.6
DK
Coloplast A/S
CSE:COLO B
27.2
22%
1.2
US
Align Technology Inc
NASDAQ:ALGN
31.3
34%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.5 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
29.9
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.8
9%
2.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
44.7
37%
1.2
CH
Ypsomed Holding AG
SIX:YPSN
19.3
32%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Average EV/EBITDA: 17.9
Negative Multiple: -23.7
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
6%
N/A
JP
Hoya Corp
TSE:7741
26.5
11%
2.4
CH
Alcon AG
SIX:ALC
16.2
8%
2
DK
Coloplast A/S
CSE:COLO B
14.2
8%
1.8
US
Align Technology Inc
NASDAQ:ALGN
16.6
19%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
18
28%
0.6
UK
ConvaTec Group PLC
LSE:CTEC
13.2
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.3
15%
1.5
JP
A
Asahi Intecc Co Ltd
TSE:7747
21
10%
2.1
CH
Ypsomed Holding AG
SIX:YPSN
12.6
21%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Average EV/EBIT: 27.7
Negative Multiple: -23.7
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
14%
N/A
JP
Hoya Corp
TSE:7741
31.9
N/A N/A
CH
Alcon AG
SIX:ALC
31.5
23%
1.4
DK
Coloplast A/S
CSE:COLO B
16.9
8%
2.1
US
Align Technology Inc
NASDAQ:ALGN
21.6
N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
58.3
72%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
21.5
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.3
11%
2
JP
A
Asahi Intecc Co Ltd
TSE:7747
28.5
N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
17.1
29%
0.6